Terms: = Liver cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Diagnosis
14 results:
1. Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.
Liu Y; Liu S; Jing R; Li C; Guo Y; Cai Z; Xi P; Dai P; Jia L; Zhu H; Zhang X
Sci Rep; 2024 Apr; 14(1):7666. PubMed ID: 38561384
[TBL] [Abstract] [Full Text] [Related]
2. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma.
Chai X; Guo J; Dong R; Yang X; Deng C; Wei C; Xu J; Han W; Lu J; Gao C; Gao D; Huang C; Ke A; Li S; Li H; Tian Y; Gu Z; Liu S; Liu H; Chen Q; Liu F; Zhou J; Fan J; Shi G; Wu F; Cai J
Clin Transl Med; 2021 Mar; 11(3):e313. PubMed ID: 33783990
[TBL] [Abstract] [Full Text] [Related]
3. MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6.
Tang Y; Yang J; Wang Y; Tang Z; Liu S; Tang Y
Arch Biochem Biophys; 2020 Jun; 686():108367. PubMed ID: 32315652
[TBL] [Abstract] [Full Text] [Related]
4. miR24-2 Promotes Malignant Progression of Human liver cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function.
Zheng Q; Zhao J; Yu H; Zong H; He X; Zhao Y; Li Y; Wang Y; Bao Y; Li Y; Chen B; Guo W; Wang Y; Chen Z; Zhao Y; Wang L; He X; Huang S
Hepatology; 2020 Jan; 71(1):259-274. PubMed ID: 31173389
[TBL] [Abstract] [Full Text] [Related]
6. Risk and survival of third primary cancers in a population-based cohort of gastric cancer patients.
Morais S; Antunes L; Bento MJ; Lunet N
Dig Liver Dis; 2019 Apr; 51(4):584-588. PubMed ID: 30591366
[TBL] [Abstract] [Full Text] [Related]
7. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract] [Full Text] [Related]
8. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant liver Tumors.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant expression of B7‑H4 may contribute to the development of hepatocellular carcinoma.
Yuan L; Dong L; Yu G; Fan W; Zhang L; Wang P; Hu X; Zhao M
Mol Med Rep; 2016 Dec; 14(6):5015-5024. PubMed ID: 27840912
[TBL] [Abstract] [Full Text] [Related]
10. Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma.
Zhang SA; Wu ZX; Zhang X; Zeng ZY; Li DL
Genet Mol Res; 2015 Oct; 14(4):13041-8. PubMed ID: 26505457
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
Zhang C; Li Y; Wang Y
J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
[TBL] [Abstract] [Full Text] [Related]
12. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract] [Full Text] [Related]
13. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
He J; Zeng ZC; Xiang ZL; Yang P
World J Gastroenterol; 2014 Mar; 20(11):3025-32. PubMed ID: 24659894
[TBL] [Abstract] [Full Text] [Related]
14. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues.
Kasper M; Stosiek P; Typlt H; Karsten U
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):137-47. PubMed ID: 2450753
[TBL] [Abstract] [Full Text] [Related]
